VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Information Disclosure
Information Disclosure
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Close Filter
Find report
Search
07/02/2024
IMP - HOSE announces the record date for 2023 dividend payment in cash and IMP shares
06/28/2024
IMP - Notice re. the last registration date to exercise the right to receive dividends of 2023
06/28/2024
IMP - Notice No. 65/IMP re. issuance of shares to pay dividends in 2023.
06/28/2024
IMP - BOD Resolution No. 10 on the record date for exercising the right to receive dividends in 2023
06/28/2024
IMP - Official letter of the SSC re. receipt of full documents reporting on share issuance to pay dividends in 2023
05/24/2024
IMP - BOD Resolution No. 09 dated May 23, 2024 re. the implementation of dividend payments in 2023
05/24/2024
IMP - BOD Resolution No. 08 dated May 23, 2024 re. the appointment of Audit Committee member
05/24/2024
IMP - BOD Resolution No. 07 dated May 23, 2024 approving the receipt of credit limits from commercial banks in 2024
05/24/2024
IMP - BOD Resolution No. 06 dated May 23, 2024 re. the selection of auditing firm in 2024
04/27/2024
Imexpharm’s Internal regulations on corporate governance - April, 2024
«
‹
1
2
3
4
5
6
7
8
9
10
›
»